β3-AR is currently regarded as one of the potential anti-obesity targets, based on the fact that β3-AR selective agonists can reduce fat storage in mature white and brown/beige adipocytes by stimulating lipolysis and thermogenesis [9,10]. This evidence concerns the gene ADRB3 and obesity due to melanocortin 4 receptor deficiency.